Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapoport

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Cathepsin B causes trogocytosis-mediated CAR T cell dysfunctionKenneth A Dietze, Kiet Nguyen, Aashli Pathni, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 26, 2025
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell TransplantDavid T Chen, Olga Goloubeva, Aaron P Rapoport, et al.
Vaccines|August 6, 2021
Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ TransplantDjordje Atanackovic, Tim Luetkens, Stephanie V Avila, et al.
Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patientsAshraf Z Badros, Olga Goloubeva, Aaron P Rapoport, et al.
American Journal of Hematology|May 24, 2019
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumabSrilakshmi Bathini, Noa G Holtzman, Rima Koka, et al.
Bone Marrow Transplantation|October 26, 2005
Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myelomaI Gojo, B Meisenberg, C Guo, et al.
Transplantation and Cellular Therapy|June 26, 2026
Predictors of Rehabilitation Utilization After CAR T-Cell TherapyHanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, et al.
Leukemia & Lymphoma|January 20, 2022
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphomaDong Won Kim, Ali Bukhari, Forat Lutfi, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Cathepsin B causes trogocytosis-mediated CAR T cell dysfunctionKenneth A Dietze, Kiet Nguyen, Aashli Pathni, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 26, 2025
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell TransplantDavid T Chen, Olga Goloubeva, Aaron P Rapoport, et al.
Vaccines|August 6, 2021
Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ TransplantDjordje Atanackovic, Tim Luetkens, Stephanie V Avila, et al.
Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patientsAshraf Z Badros, Olga Goloubeva, Aaron P Rapoport, et al.
American Journal of Hematology|May 24, 2019
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumabSrilakshmi Bathini, Noa G Holtzman, Rima Koka, et al.
Bone Marrow Transplantation|October 26, 2005
Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myelomaI Gojo, B Meisenberg, C Guo, et al.
Transplantation and Cellular Therapy|June 26, 2026
Predictors of Rehabilitation Utilization After CAR T-Cell TherapyHanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, et al.
Leukemia & Lymphoma|January 20, 2022
Low utility of the H-Score and HLH-2004 criteria to identify patients with secondary hemophagocytic lymphohistiocytosis after CAR-T cell therapy for relapsed/refractory diffuse large B-Cell lymphomaDong Won Kim, Ali Bukhari, Forat Lutfi, et al.
Pageof 18